Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elizabeth McFarland

Concepts (381)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
26
2025
863
2.870
Why?
HIV Infections
48
2025
2828
2.860
Why?
Respiratory Syncytial Virus Vaccines
6
2022
36
2.350
Why?
Respiratory Syncytial Virus Infections
6
2022
127
2.150
Why?
Respiratory Syncytial Virus, Human
6
2022
74
2.140
Why?
Infectious Disease Transmission, Vertical
18
2025
182
2.110
Why?
HIV Antibodies
12
2025
62
2.040
Why?
Anti-Retroviral Agents
12
2023
233
1.740
Why?
Viral Proteins
3
2020
340
1.570
Why?
Antibodies, Viral
8
2022
624
1.130
Why?
Antibodies, Neutralizing
8
2025
285
1.090
Why?
Colonography, Computed Tomographic
3
2024
8
0.970
Why?
Anti-HIV Agents
11
2025
775
0.870
Why?
Antibodies, Monoclonal
6
2025
1430
0.870
Why?
AIDS Vaccines
8
2018
52
0.850
Why?
Pregnancy Complications, Infectious
8
2016
390
0.760
Why?
Gene Deletion
2
2020
389
0.730
Why?
Breast Feeding
4
2025
439
0.650
Why?
Atazanavir Sulfate
2
2017
41
0.640
Why?
HIV Protease Inhibitors
2
2017
69
0.620
Why?
Ritonavir
2
2017
74
0.620
Why?
Vaccination
6
2020
1377
0.580
Why?
HIV Envelope Protein gp120
6
2017
60
0.580
Why?
Vaccines, Attenuated
6
2022
131
0.580
Why?
Infant, Newborn
23
2025
6033
0.580
Why?
Incidental Findings
1
2018
87
0.550
Why?
Radiation Dosage
1
2018
175
0.510
Why?
Infant
31
2025
9398
0.510
Why?
Nelfinavir
1
2016
9
0.510
Why?
Lopinavir
1
2016
30
0.500
Why?
Syncope
1
2016
52
0.500
Why?
Bradycardia
1
2016
55
0.490
Why?
Patient Dropouts
1
2016
67
0.490
Why?
Lyme Disease
1
2016
60
0.480
Why?
Health Resources
1
2016
119
0.470
Why?
Infant, Newborn, Diseases
1
2016
113
0.450
Why?
HIV
5
2014
234
0.420
Why?
Patient Compliance
2
2018
577
0.400
Why?
Immunogenicity, Vaccine
4
2021
30
0.390
Why?
Referral and Consultation
1
2018
780
0.380
Why?
Child
37
2025
21822
0.380
Why?
Humans
74
2025
136768
0.370
Why?
T-Lymphocytes, Cytotoxic
4
2005
173
0.360
Why?
CD4-Positive T-Lymphocytes
2
2017
1095
0.360
Why?
Virus Replication
4
2020
482
0.350
Why?
Female
48
2025
72796
0.340
Why?
Lymphocyte Activation
5
2017
1150
0.310
Why?
Male
39
2025
67311
0.300
Why?
Adolescent
27
2025
21382
0.290
Why?
Viral Load
9
2017
464
0.280
Why?
HIV Seropositivity
2
2023
125
0.280
Why?
Bone Density
2
2025
487
0.270
Why?
Double-Blind Method
3
2020
1981
0.260
Why?
RNA, Viral
8
2023
654
0.250
Why?
Antibodies, Bacterial
2
2018
146
0.240
Why?
Antiretroviral Therapy, Highly Active
6
2017
271
0.230
Why?
Dyslipidemias
2
2017
176
0.230
Why?
Bone Development
1
2025
54
0.230
Why?
Immunoenzyme Techniques
1
2005
219
0.220
Why?
Immunoglobulin G
3
2022
887
0.220
Why?
Viremia
3
2011
138
0.220
Why?
Diverticulum
1
2024
12
0.220
Why?
Gene Products, gag
2
1994
36
0.210
Why?
Mammography
1
2025
152
0.210
Why?
Child, Preschool
21
2022
11000
0.210
Why?
Young Adult
12
2021
13129
0.200
Why?
Squalene
3
2017
7
0.200
Why?
Pregnancy
11
2023
6728
0.200
Why?
Complementarity Determining Regions
1
2002
51
0.190
Why?
Drug Resistance, Viral
2
2016
116
0.190
Why?
CD4 Lymphocyte Count
4
2017
269
0.190
Why?
Half-Life
1
2021
164
0.180
Why?
Growth Differentiation Factor 15
1
2021
40
0.180
Why?
Mitochondrial Diseases
1
2021
91
0.180
Why?
Immunization Schedule
2
2018
195
0.170
Why?
Drug Therapy, Combination
4
2017
1062
0.170
Why?
Fibroblast Growth Factors
1
2021
171
0.170
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
337
0.170
Why?
T-Lymphocytes
2
2009
1993
0.170
Why?
RNA, Small Untranslated
1
2020
16
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.160
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
187
0.160
Why?
Cytokines
2
2021
2084
0.160
Why?
Body Temperature
1
2020
221
0.150
Why?
Point Mutation
1
2020
235
0.150
Why?
Haemophilus Vaccines
2
2018
30
0.150
Why?
Insulin Resistance
3
2019
1203
0.150
Why?
Immunocompromised Host
2
2000
202
0.150
Why?
Immunologic Memory
2
2021
370
0.150
Why?
Darunavir
1
2017
19
0.140
Why?
Interleukin-12
1
1998
121
0.140
Why?
Metabolic Syndrome
1
2021
354
0.140
Why?
CD8-Positive T-Lymphocytes
2
2011
913
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
360
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Dose-Response Relationship, Drug
1
2021
2052
0.130
Why?
Interferon-gamma
5
2012
789
0.130
Why?
Lymphopoiesis
1
2017
26
0.130
Why?
Uganda
1
2017
77
0.130
Why?
Antibody Formation
1
2018
298
0.130
Why?
Immunoglobulin A
2
2017
210
0.130
Why?
Receptors, CCR5
1
2017
59
0.130
Why?
High-Throughput Screening Assays
1
2018
158
0.130
Why?
CD4-CD8 Ratio
1
2016
22
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.130
Why?
Adoption
1
2016
30
0.130
Why?
Mothers
3
2017
752
0.120
Why?
Cohort Studies
8
2025
5701
0.120
Why?
Virus Latency
1
2016
82
0.120
Why?
Continuity of Patient Care
1
2018
281
0.120
Why?
Early Diagnosis
1
2016
240
0.120
Why?
Chickenpox Vaccine
1
2015
73
0.120
Why?
Zimbabwe
2
2025
58
0.120
Why?
Body Height
2
2017
199
0.120
Why?
Gene Products, env
1
1994
6
0.110
Why?
Adult
15
2023
37630
0.110
Why?
Disease Susceptibility
1
2017
345
0.110
Why?
Haemophilus influenzae type b
1
2014
12
0.110
Why?
Bacterial Capsules
1
2014
30
0.110
Why?
Chickenpox
1
2015
83
0.110
Why?
Antibody Affinity
1
2014
60
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
230
0.110
Why?
South Africa
2
2025
217
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
Vaccines, Synthetic
4
2005
126
0.110
Why?
Developing Countries
1
2016
306
0.110
Why?
Puberty, Delayed
1
2013
5
0.110
Why?
Cytotoxicity, Immunologic
3
2002
225
0.110
Why?
Intestines
1
2017
357
0.110
Why?
Leukocytes, Mononuclear
4
2013
558
0.100
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Mycobacterium chelonae
1
1993
9
0.100
Why?
Retrospective Studies
8
2023
15504
0.100
Why?
Vaccines
1
2018
405
0.100
Why?
Lipids
1
2017
665
0.100
Why?
Patient Selection
1
2017
690
0.100
Why?
Colorectal Neoplasms
1
2020
791
0.100
Why?
Lamivudine
3
2023
63
0.100
Why?
Breast Neoplasms
1
2025
2234
0.100
Why?
Cell Movement
1
2017
968
0.100
Why?
Child Development
1
2017
464
0.090
Why?
Mitochondria
2
2021
946
0.090
Why?
Pediatric Obesity
1
2019
590
0.090
Why?
Clinical Trials as Topic
1
2017
1044
0.090
Why?
STAT1 Transcription Factor
1
2012
73
0.090
Why?
Cardiovascular Diseases
2
2016
2104
0.090
Why?
Body Fat Distribution
1
2011
49
0.090
Why?
Body Weight
2
2017
985
0.090
Why?
Polysorbates
3
2017
41
0.090
Why?
Prospective Studies
4
2017
7572
0.090
Why?
Mycobacterium avium Complex
1
2012
88
0.090
Why?
Epitopes
2
2022
480
0.090
Why?
Cost-Benefit Analysis
2
2025
587
0.090
Why?
United States
9
2023
14691
0.090
Why?
Biomedical Research
1
2017
688
0.080
Why?
Research Design
1
2017
1127
0.080
Why?
Interleukin-2
2
2003
455
0.080
Why?
Respiratory Tract Infections
1
2014
394
0.080
Why?
Exercise
1
2021
2043
0.080
Why?
Prenatal Exposure Delayed Effects
1
2016
605
0.080
Why?
Freezing
1
2009
90
0.080
Why?
Absorptiometry, Photon
2
2025
254
0.080
Why?
Blood
1
2009
107
0.080
Why?
Algorithms
1
2016
1689
0.070
Why?
Staff Development
1
2009
56
0.070
Why?
Phenotype
1
2017
3189
0.070
Why?
Age Factors
4
2019
3284
0.070
Why?
T-Lymphocyte Subsets
2
2002
425
0.070
Why?
Biomarkers
4
2021
4144
0.070
Why?
Lymphocyte Subsets
2
2009
87
0.070
Why?
Longitudinal Studies
3
2025
2829
0.070
Why?
Specimen Handling
1
2009
181
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
851
0.070
Why?
Enterovirus A, Human
1
2007
13
0.070
Why?
Faculty
1
2009
146
0.070
Why?
Withholding Treatment
1
2008
76
0.070
Why?
Adipose Tissue
1
2011
630
0.070
Why?
Central Nervous System Viral Diseases
1
2007
79
0.060
Why?
Polymerase Chain Reaction
4
2011
1059
0.060
Why?
Flow Cytometry
3
2009
1180
0.060
Why?
DNA, Viral
2
2000
363
0.060
Why?
Academic Medical Centers
1
2009
504
0.060
Why?
False Negative Reactions
1
2025
53
0.060
Why?
Isoantigens
1
1984
15
0.060
Why?
Cell Line
3
2012
2838
0.060
Why?
Medical Audit
1
2025
78
0.060
Why?
C-Reactive Protein
2
2021
408
0.060
Why?
Enterovirus Infections
1
2007
177
0.060
Why?
Immunity, Cellular
1
2006
268
0.060
Why?
Colorado
3
2023
4518
0.060
Why?
Follow-Up Studies
3
2021
5106
0.050
Why?
Linear Models
2
2020
846
0.050
Why?
Disease Outbreaks
1
2007
387
0.050
Why?
Confusion
1
2024
28
0.050
Why?
Comorbidity
2
2021
1614
0.050
Why?
Sequence Analysis, DNA
2
2007
809
0.050
Why?
Thymus Gland
1
1984
313
0.050
Why?
Tablets
1
2023
40
0.050
Why?
Constriction, Pathologic
1
2024
242
0.050
Why?
Risk Factors
4
2021
10326
0.050
Why?
Regression Analysis
2
2021
1022
0.050
Why?
Respiratory Syncytial Viruses
1
2022
52
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
22
0.050
Why?
Immunophenotyping
2
1994
319
0.050
Why?
Zidovudine
2
2015
78
0.050
Why?
Clone Cells
1
2002
266
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
82
0.050
Why?
Cough
1
2022
122
0.050
Why?
Emtricitabine
1
2023
175
0.050
Why?
Vaccines, Subunit
1
2001
49
0.050
Why?
Pyridones
1
2023
168
0.040
Why?
Tenofovir
1
2023
243
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
50
0.040
Why?
Lung
1
2014
4062
0.040
Why?
Ganciclovir
1
2000
53
0.040
Why?
Public Health Surveillance
1
2021
79
0.040
Why?
Computer Simulation
1
2005
973
0.040
Why?
Adjuvants, Immunologic
2
2017
226
0.040
Why?
Africa
1
2020
108
0.040
Why?
Injections, Subcutaneous
1
2020
154
0.040
Why?
Diagnostic Tests, Routine
1
2021
110
0.040
Why?
Symptom Assessment
1
2021
128
0.040
Why?
Cross-Sectional Studies
3
2021
5423
0.040
Why?
Sex Factors
2
2019
2060
0.040
Why?
HIV Seronegativity
1
2019
28
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Risk
1
2021
908
0.040
Why?
Case-Control Studies
2
2019
3540
0.040
Why?
Cytomegalovirus Infections
1
2000
192
0.040
Why?
Prevalence
2
2016
2711
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
50
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
41
0.040
Why?
Vaccines, Combined
1
2018
48
0.040
Why?
Cholesterol, HDL
1
2019
203
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
Why?
Hospitals
1
2023
685
0.040
Why?
Amino Acid Sequence
1
2002
2138
0.040
Why?
Hepatitis B Vaccines
1
2018
45
0.040
Why?
Odds Ratio
1
2021
1065
0.040
Why?
Mutation
3
2018
3946
0.040
Why?
Drug Resistance, Microbial
2
2000
71
0.040
Why?
Colon
1
2020
282
0.040
Why?
Molecular Sequence Data
1
2002
2894
0.030
Why?
Nutrition Surveys
1
2019
266
0.030
Why?
Case Management
1
2018
66
0.030
Why?
Antigens, Viral
1
1998
181
0.030
Why?
Cholesterol
1
2019
410
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
187
0.030
Why?
Cholesterol, LDL
1
2019
365
0.030
Why?
Immune Tolerance
1
1999
362
0.030
Why?
Treatment Adherence and Compliance
1
2017
26
0.030
Why?
Triglycerides
1
2019
524
0.030
Why?
Reproducibility of Results
1
2005
3264
0.030
Why?
Disease Management
1
2021
624
0.030
Why?
Lymphocyte Count
2
2009
150
0.030
Why?
Cell Division
1
1998
796
0.030
Why?
Uncertainty
1
2017
128
0.030
Why?
Treatment Failure
1
2017
354
0.030
Why?
Multicenter Studies as Topic
1
2017
308
0.030
Why?
Nevirapine
1
2015
17
0.030
Why?
Seroepidemiologic Studies
1
2015
165
0.030
Why?
Time-to-Treatment
1
2017
204
0.030
Why?
Maternal Exposure
1
2017
188
0.030
Why?
Malnutrition
1
2016
82
0.030
Why?
Patient Outcome Assessment
1
2016
131
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1462
0.030
Why?
Antiviral Agents
1
2000
739
0.030
Why?
Coinfection
1
2016
137
0.030
Why?
Treatment Outcome
2
2021
10744
0.030
Why?
Vaccines, Conjugate
1
2014
65
0.030
Why?
Neutropenia
1
2015
146
0.030
Why?
Counseling
1
2018
388
0.030
Why?
Sexual and Gender Minorities
1
2018
213
0.030
Why?
Cells, Cultured
2
2008
4191
0.030
Why?
Global Health
1
2017
385
0.030
Why?
Anemia
1
2015
170
0.030
Why?
Maternal-Fetal Exchange
1
2014
165
0.030
Why?
Electron Transport Complex IV
1
2013
60
0.030
Why?
Electron Transport Complex I
1
2013
41
0.030
Why?
Medication Adherence
1
2017
466
0.030
Why?
Thrombocytopenia
1
2015
198
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
31
0.030
Why?
Radiography, Thoracic
1
2014
167
0.030
Why?
CD8 Antigens
1
1993
75
0.030
Why?
Severity of Illness Index
1
2021
2822
0.020
Why?
CD3 Complex
1
1993
106
0.020
Why?
Drug Administration Schedule
2
2008
785
0.020
Why?
Oxidative Phosphorylation
1
2013
193
0.020
Why?
Lymphocytes
1
1994
393
0.020
Why?
Blood Pressure
1
2019
1774
0.020
Why?
DNA, Mitochondrial
1
2013
200
0.020
Why?
P-Selectin
1
2011
28
0.020
Why?
Blood Transfusion
1
1994
323
0.020
Why?
E-Selectin
1
2011
57
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Pandemics
1
2020
1613
0.020
Why?
Tuberculosis, Pulmonary
1
1993
141
0.020
Why?
Antigens, CD
1
1994
521
0.020
Why?
Chemokine CCL2
1
2011
115
0.020
Why?
Hospitalization
1
2021
2183
0.020
Why?
Hyperlipidemias
1
2011
120
0.020
Why?
Cell Proliferation
2
2009
2475
0.020
Why?
Fibrinogen
1
2011
167
0.020
Why?
Protein Multimerization
1
2012
191
0.020
Why?
Interferon-alpha
1
2012
198
0.020
Why?
Nontuberculous Mycobacteria
1
1993
205
0.020
Why?
Cell Adhesion Molecules
1
2011
181
0.020
Why?
Healthcare Disparities
1
2017
649
0.020
Why?
Cross Infection
1
1993
252
0.020
Why?
Infant, Premature
1
1994
566
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
Diagnosis, Differential
1
2014
1481
0.020
Why?
L-Selectin
1
2009
26
0.020
Why?
Human Experimentation
1
2009
13
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
37
0.020
Why?
Leukocyte Common Antigens
1
2009
87
0.020
Why?
Obesity
1
2021
2982
0.020
Why?
Multivariate Analysis
1
2011
1507
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Virus Cultivation
1
2007
29
0.020
Why?
Phosphorylation
1
2012
1758
0.020
Why?
Interleukin-6
1
2011
778
0.020
Why?
Pregnancy Outcome
1
2010
412
0.020
Why?
Cerebrospinal Fluid
1
2007
92
0.020
Why?
Data Interpretation, Statistical
1
2009
363
0.020
Why?
Paralysis
1
2007
70
0.020
Why?
Multiple Organ Failure
1
2007
127
0.020
Why?
B-Lymphocytes
1
2012
846
0.020
Why?
Kinetics
1
2010
1664
0.020
Why?
Respiratory System
1
2007
157
0.020
Why?
Genotype
1
2011
1914
0.020
Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
Why?
Cell Survival
1
2009
1116
0.020
Why?
Phosphates
1
1987
182
0.020
Why?
Muscles
1
1987
325
0.020
Why?
Encephalitis
1
2007
136
0.020
Why?
Gastrointestinal Tract
1
2007
195
0.010
Why?
Mucous Membrane
1
2005
125
0.010
Why?
Chemistry, Physical
1
1984
37
0.010
Why?
Antigen-Antibody Reactions
1
1984
55
0.010
Why?
Chemical Phenomena
1
1984
83
0.010
Why?
DNA-Binding Proteins
1
2012
1501
0.010
Why?
Myasthenia Gravis
1
1984
23
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
69
0.010
Why?
Saliva
1
2005
242
0.010
Why?
Tissue Distribution
1
1984
330
0.010
Why?
Tomography, X-Ray Computed
1
2014
2667
0.010
Why?
Aging
2
2003
1864
0.010
Why?
Epithelium
1
1984
311
0.010
Why?
Blood Glucose
1
2013
2181
0.010
Why?
Body Mass Index
1
2011
2375
0.010
Why?
Middle Aged
2
2020
33228
0.010
Why?
Infusions, Intravenous
1
2003
412
0.010
Why?
Anti-Bacterial Agents
1
1993
1798
0.010
Why?
Reference Values
1
2003
816
0.010
Why?
Mice, Inbred BALB C
1
1984
1269
0.010
Why?
Suspensions
1
2000
36
0.010
Why?
Capsules
1
2000
38
0.010
Why?
Urban Population
1
2003
476
0.010
Why?
Drug Tolerance
1
2000
105
0.010
Why?
Cytomegalovirus
1
2000
157
0.010
Why?
Signal Transduction
1
2012
5076
0.010
Why?
Administration, Oral
1
2000
813
0.010
Why?
Epithelial Cells
1
1984
1094
0.010
Why?
Immunization
1
2000
411
0.010
Why?
Time Factors
1
2008
6808
0.010
Why?
Recombinant Proteins
1
2000
1350
0.010
Why?
Macrophages
1
1984
1544
0.010
Why?
Tail
1
1987
28
0.000
Why?
Mice
1
1984
17757
0.000
Why?
Phosphocreatine
1
1987
46
0.000
Why?
Salamandridae
1
1987
33
0.000
Why?
Animals
2
1987
36847
0.000
Why?
Aged
1
1984
23794
0.000
Why?
Adenosine Triphosphate
1
1987
487
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
610
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)